CMA Accuses Pharmas Of Divvying Market For UTI Treatment
A pair of British drugmakers and a wholesaler may have cut into antitrust laws with a yearslong deal to carve up the market for an antibiotic that treats urinary tract infections,...To view the full article, register now.
Already a subscriber? Click here to view full article